Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets (Q37810915)

23 August 2017

title

Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets (English)

1 reference

23 August 2017

0 references

1 reference

1

0 references

Claudia Monaco

series ordinal

3

0 references

author name string

Anuja T Mitra

series ordinal

2

1 reference

23 August 2017

publication date

1 November 2010

1 reference

Expert Review of Cardiovascular Therapy

23 August 2017

published in

1 reference

23 August 2017

volume

8

1 reference

23 August 2017

issue

11

1 reference

23 August 2017

page(s)

1619-1635

1 reference

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Discovery of the role of wall shear in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Oxidized phospholipids trigger atherogenic inflammation in murine arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Blood monocytes consist of two principal subsets with distinct migratory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Monocyte and macrophage heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Migratory fate and differentiation of blood monocyte subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Innate immunity, macrophage activation, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Innate and adaptive immunity in the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Targeting Toll-like receptors: emerging therapeutics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

21 January 2018

TLR signaling pathways

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

CD36 is a sensor of diacylglycerides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Pattern recognition receptors and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Intracellular toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

IRF3 mediates a TLR3/TLR4-specific antiviral gene program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Discrimination of bacterial lipoproteins by Toll-like receptor 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Extended exposure of lipopolysaccharide fraction from Porphyromonas gingivalis facilitates mononuclear cell adhesion to vascular endothelium via Toll-like receptor-2 dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Double-stranded RNA-mediated TLR3 activation is enhanced by CD14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Toll-like receptors, endogenous ligands, and systemic autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Hyaluronan fragments act as an endogenous danger signal by engaging TLR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Hyaluronan fragments stimulate endothelial recognition of injury through TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

mRNA is an endogenous ligand for Toll-like receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

The microtubule regulator stathmin is an endogenous protein agonist for TLR3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Vessel-specific Toll-like receptor profiles in human medium and large arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Toll-like receptor 4 expressions on peripheral blood monocytes were enhanced in coronary artery disease even in patients with low C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Oxidized low-density lipoprotein correlates positively with toll-like receptor 2 and interferon regulatory factor-1 and inversely with superoxide dismutase-1 expression: studies in hypercholesterolemic swine and THP-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Acute modulation of toll-like receptors by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of Vascular Dendritic Cells in athero-resistant and athero-prone areas of the normal aorta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Subcellular localization of Toll-like receptor 3 in human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Mast-cell responses to pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and Fc RI

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Substance P primes lipoteichoic acid- and Pam3CysSerLys4-mediated activation of human mast cells by up-regulating Toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Flow-dependent regulation of endothelial Toll-like receptor 2 expression through inhibition of SP1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

c-Jun N-terminal kinase primes endothelial cells at atheroprone sites for apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Toll-like receptor 3 signaling evokes a proinflammatory and proliferative phenotype in human vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

TLR-4 agonistic lipopolysaccharide upregulates interleukin-8 at the transcriptional and post-translational level in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Potential role of endotoxin as a proinflammatory mediator of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Differential expression of Toll-like receptor 2 (TLR2) and responses to TLR2 ligands between human and murine vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Early growth response-1 is involved in foam cell formation and is upregulated by the TLR9-MyD88-ERK1/2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Chlamydia pneumoniae--induced macrophage foam cell formation is mediated by Toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Toll-like receptors induce a phagocytic gene program through p38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

ADRP/ADFP and Mal1 expression are increased in macrophages treated with TLR agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Crosstalk between LXR and Toll-like Receptor Signaling Mediates Bacterial and Viral Antagonism of Cholesterol Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Atherosclerosis and plasma and liver lipids in nine inbred strains of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Modulation of atherosclerosis in mice by Toll-like receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Toll-like receptors in the pathogenesis of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Mechanisms of disease: Toll-like receptors in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Targeting signal transduction as a strategy to treat inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Toll-like receptor 4 antagonist (E5564) prevents the chronic airway response to inhaled lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

A phase II, double-blind, placebo-controlled, ascending-dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Pharmacological inhibitors of MAPK pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Adding fuel to fire: microRNAs as a new class of mediators of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Inositol phosphatase SHIP1 is a primary target of miR-155

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Circulating microRNAs in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

MiR-33 contributes to the regulation of cholesterol homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Enhanced Response of Blood Monocytes to In Vitro Lipopolysaccharide-Challenge in Patients With Recurrent Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

Toll-like Receptor 4 Polymorphisms and Atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.149

T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors.

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1096/FJ.02-1139FJE

Identifiers

DOI

10.1586/ERC.10.149

1 reference

23 August 2017

1 reference